1-3 of 3
Nathan Moore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

Scott R. Goldsmith, Fahrettin Covut, Mark A. Fiala, Elizabeth Bradtke, Ayan Gasanli, Brandon Christen, Jonathan A. Pachter, Zhifu Xiang, Zahid Iqbal, Nathan Moore, Uchenna Ofoma, Bijal Parikh, Erik Dubberke, John F. DiPersio
Journal: Blood
Blood (2022) 140 (Supplement 1): 11185–11186.
https://doi.org/10.1182/blood-2022-157605
Published: 2022
Journal Articles

Deletion of AMP-Activated Protein Kinase (AMPK) in Donor T Cells Protects Against Graft-Verus-Host Disease through Control of Regulatory T Cell Expansion and Target Organ Infiltration

Kevin Beezhold, PhD, Nathan Moore, Pailin Chiaranunt, Rebecca Brown, Craig A. Byersdorfer, MD PhD
Journal: Blood
Blood (2016) 128 (22): 806.
https://doi.org/10.1182/blood.V128.22.806.806
Published: 2016
Journal Articles

Mesenchymal Stem Cells (MSC) Promote Aggressive Behavior of Human Breast Cancer Cells (MCF-7) in Vitro- the Role Cytokines (TNF-alpha) and Chemokines

Jan Cerny, MD, Yingwang Liu, MD, Nathan Moore, Glennice Bowen, BS, Anna M Cerny, BS, Evelyn Kurt-Jones, PhD, Susan Erdman, DVM, MPH, JeanMarie Houghton, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4750.
https://doi.org/10.1182/blood.V112.11.4750.4750
Published: 2008